The session “Harnessing the Power of Nature: A One Health Approach Against Acanthamoeba” will be one of the key events at UNGA79, focusing on the urgent need to tackle Acanthamoeba infections, which pose a significant and growing threat to global health.
Early data from Roche’s Alzheimer’s therapy show it’s hitting targets
An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ brains, the company reported Wednesday, adding to
October 30, 2024